Literature DB >> 4531383

Increased excretion of a glucose-containing tetrasaccharide in the urine of a patient with glycogen storage disease type II (Pompe's disease).

P Hallgren, G Hansson, K G Henriksson, A Häger, A Lundblad, S Svensson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4531383     DOI: 10.1111/j.1365-2362.1974.tb00416.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  10 in total

Review 1.  Are there useful biochemical markers of disease activity in lysosomal storage diseases?

Authors:  B Winchester
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease.

Authors:  Haiqing Yi; Tao Sun; Dustin Armstrong; Scott Borneman; Chunyu Yang; Stephanie Austin; Priya S Kishnani; Baodong Sun
Journal:  J Mol Med (Berl)       Date:  2017-02-02       Impact factor: 4.599

Review 3.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

Review 4.  Urinary oligosaccharides in lysosomal and other metabolic disorders.

Authors:  A Federico; G Guazzi
Journal:  Ital J Neurol Sci       Date:  1982-03

5.  Determination of a glucose-containing tetrasaccharide in urine of patients with acute pancreatitis.

Authors:  J Kumlien; A Andrén-Sandberg; D Zopf; A Lundblad
Journal:  Int J Pancreatol       Date:  1989-03

6.  Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid.

Authors:  Silvia Nitschke; Sara Petković; Saija Ahonen; Berge A Minassian; Felix Nitschke
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

7.  Urinary oligosaccharide excretion in disorders of glycolipid, glycoprotein and glycogen metabolism. A review of screening for differential diagnosis.

Authors:  A C Sewell
Journal:  Eur J Pediatr       Date:  1980-09       Impact factor: 3.183

8.  Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort.

Authors:  Monique Piraud; Magali Pettazzoni; Marie de Antonio; Christine Vianey-Saban; Roseline Froissart; Brigitte Chabrol; Sarah Young; Pascal Laforêt
Journal:  Mol Genet Metab Rep       Date:  2020-05-01

9.  Diurnal variability of glucose tetrasaccharide (Glc4) excretion in patients with glycogen storage disease type III.

Authors:  Sarah P Young; Aleena Khan; Ela Stefanescu; Andrea M Seifts; Ghada Hijazi; Stephanie Austin; Priya S Kishnani
Journal:  JIMD Rep       Date:  2020-11-03

10.  Experience with the Urinary Tetrasaccharide Metabolite for Pompe Disease in the Diagnostic Laboratory.

Authors:  Jennifer T Saville; Maria Fuller
Journal:  Metabolites       Date:  2021-07-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.